SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-211400
Filing Date
2013-05-09
Accepted
2013-05-09 17:10:24
Documents
12
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d506861d10q.htm 10-Q 575959
2 EX-10.1 d506861dex101.htm EX-10.1 15861
3 EX-10.2 d506861dex102.htm EX-10.2 66453
4 EX-31.1 d506861dex311.htm EX-31.1 8976
5 EX-31.2 d506861dex312.htm EX-31.2 9051
6 EX-32_1 d506861dex321.htm EX-32.1 4903
  Complete submission text file 0001193125-13-211400.txt   3607182

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arna-20130331.xml EX-101.INS 408262
8 XBRL TAXONOMY EXTENSION SCHEMA arna-20130331.xsd EX-101.SCH 38177
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20130331_cal.xml EX-101.CAL 47061
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20130331_def.xml EX-101.DEF 217642
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20130331_lab.xml EX-101.LAB 301312
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20130331_pre.xml EX-101.PRE 257249
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 13829889
SIC: 2834 Pharmaceutical Preparations